A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Epilepsy, Partial
Interventions
DRUG

Levetiracetam

Dosing was stratified by age. A dose of 20 mg/kg/day titrating to 40 mg/kg/day for children one month to less than six months old and a dose of 25 mg/kg/day titrating to 50 mg/kg/day for children 6 month to less than 4 years old, was used in this study. The total daily dose was administered b.i.d.

OTHER

Placebo

Placebo solution, which is indistinguishable from the Levetiracetam oral solution.

Trial Locations (86)

Unknown

Birmingham

Mobile

Tucson

Little Rock

Los Angeles

Gainesville

Loxahatchee Groves

Miami

Tallahassee

Tampa

Augusta

Boise

Chicago

New Orleans

Boston

Detroit

Saint Paul

Lebanon

Cherry Hill

Edison

Buffalo

New York

Rochester

Syracuse

Chapel Hill

Winston-Salem

Cincinnati

Cleveland

Columbus

Portland

Danville

Hershey

Philadelphia

Spartanburg

Nashville

Dallas

Fort Worth

Salt Lake City

Richmond

Seattle

Morgantown

Milwaukee

Buenos Aires

Mendoza

Pilar Buenos Aires

Brussels

Leuven

Campinas

Curitiba

Porto Alegre

Ribeirão Preto

Rio de Janeiro

São Paulo

Vancouver

Winnepeg

St. John's

London

Scarborough Village

Saskatoon

Brno

Prague

Lille

Paris

Rouen

Strasbourg

Kehl

Berlin

Erlangen

Heidelberg

Jena

Kiel

Budapest

Calambrone

Genoa

Milan

Roma

Mexico City

Gdansk

Bucharest

Cluj-Napoca

Târgu Mureş

Kalingrad

Moscow

Saint Petersburg

Glasgow

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY